Noradrenaline for management of septic shock refractory to fluid loading and dopamine or dobutamine in full-term newborn infants

Acta Paediatr. 2008 Feb;97(2):177-80. doi: 10.1111/j.1651-2227.2007.00601.x. Epub 2008 Jan 3.

Abstract

Aim: To determine the effects of noradrenaline in full-term newborns with refractory septic shock.

Methods: Newborns of >35 weeks' gestation with persistent septic shock, despite adequate fluid resuscitation and high dose of dopamine/dobutamine were eligible. In this prospective observational study, we recorded respiratory and hemodynamic parameters prior to and 3 h after starting noradrenaline infusion.

Results: Twenty-two newborns were included (gestational age [GA] 39 +/- 1.7 weeks, birth weight (BW) 3110 +/- 780 g). Before starting noradrenaline, the infants received a mean volume expansion of 31 +/- 15 mL/kg and a mean infusion rate of dopamine of 14 +/- 5 microg/kg/min or dobutamine of 12 +/- 6 microg/kg/min. Three hours after starting noradrenaline (rate 0.5 +/- 0.4 microg/kg/min), the mean arterial blood pressure rose from 36 +/- 5 to 51 +/- 7 mmHg (p < 0.001). Urine output increased from 1 +/- 0.5 to 1.7 +/- 0.4 mL/kg/h (p < 0.05). Blood lactate concentration decreased from 4.8 +/- 2.3 to 3.3 +/- 1.8 mmol/L (p < 0.01). Despite an initial correction of hypotension, four infants died later.

Conclusion: Noradrenaline was effective in increasing systemic blood pressure. An increase in urine output and a decrease in blood lactate concentration suggest that noradrenaline may have improved cardiac function and tissue perfusion.

MeSH terms

  • Blood Pressure / drug effects
  • Dobutamine / therapeutic use
  • Dopamine / therapeutic use
  • Fluid Therapy
  • Humans
  • Infant, Newborn
  • Lactates / blood
  • Norepinephrine / therapeutic use*
  • Prospective Studies
  • Shock, Septic / drug therapy*
  • Shock, Septic / therapy
  • Vasoconstrictor Agents / therapeutic use*

Substances

  • Lactates
  • Vasoconstrictor Agents
  • Dobutamine
  • Dopamine
  • Norepinephrine